These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22183703)

  • 41. Consultative Interpretation for Lupus Anticoagulant by Expert Pathologist Reduces False-Positive Rates in the Era of Direct Oral Anticoagulants.
    Vivero A; Kitahara S; Runge A; Volod O
    J Appl Lab Med; 2020 Jan; 5(1):73-82. PubMed ID: 31811080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V; Biasiolo A; Pegoraro C; Iliceto S
    J Thromb Haemost; 2004 May; 2(5):702-7. PubMed ID: 15099274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The frequency and potential clinical impact of non-analytical errors in the RCPA Microbiology QAP 1987-2008.
    Morris AJ; Haremza E; Walker DA
    Pathology; 2011 Jun; 43(4):346-9. PubMed ID: 21519289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory diagnosis of lupus anticoagulant].
    Swadźba J; Musiał J; Jankowski M; Bednarczyk M; Dyczek A; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
    Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
    Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
    Devreese KM; de Laat B
    J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
    Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
    J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays.
    Pradella P; Azzarini G; Santarossa L; Caberlotto L; Bardin C; Poz A; D'Aurizio F; Giacomello R
    Clin Chem Lab Med; 2013 Feb; 51(2):379-85. PubMed ID: 23001319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory identification of lupus anticoagulants.
    Smock KJ; Rodgers GM
    Am J Hematol; 2009 Jul; 84(7):440-2. PubMed ID: 19384933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature.
    Vivaldi P; Rossetti G; Galli M; Finazzi G
    Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
    Moore GW
    Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.